| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |